Page 12 - Agent Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article PHILADELPHIA, Jan. 7, 2021 /PRNewswire/ -- CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today that it has completed its Series B equity financing providing for gross proceeds of $47 million, bringing CARISMA's total capital raised to nearly $109 million. The funding will be used to advance current pipeline and discovery programs, including the Phase I clinical trial of CARISMA's lead candidate, CT-0508, an anti-human epidermal growth factor receptor 2 (HER2) targeted ...

600 kilometers of what will turn out to be kidney softening travel by rail. but myanmar's agent capital, i have been told, is is a must-see. >> the true experience. the engine is a french engine from the '70s. >> we have been told it's a somewhat uncomfortable ten-hour trip. so really the question on this end of the journey is come back on train or fly in coffin? >> mishaps on both planes and trains are not, shall we say, unheard of. >> widow maker express. >> that is the choice. that may be the signal to depart at some point. >> all aboard. >> whoa, we're moving. >> here we go.